(HealthDay News) -- Here are the latest clinical trials,
This study is evaluating an investigational product designed to
enhance the central nervous system of adults with diagnosed
relapsing, remitting or secondary progressive MS. To qualify, you
must be aged 18 to 60 and attend eight overnight stays over a
The research site is in Phoenix, Ariz.
This study of an investigational drug is for people who have
been treated unsatisfactorily for hepatitis C.
The research site is in La Mesa, Calif.
Systemic Lupus Erythematosus (SLE)
This study is for people diagnosed with systemic lupus
erythematosus, specifically with high anti-dsDNA and anti-RNP.
The research site is in Everett, Wash.
ClinicalConnection.com. All rights reserved.